For many people, rheumatoid arthritis seems to appear suddenly. One day they begin experiencing painful, swollen joints, ...
By Karen Roman Imviva Biotech said the FDA cleared its Investigational New Drug application for CTA313, a dual-targeted CAR-T ...
Everyday Health on MSN
GLP-1 drugs may offer big heart protection for adults with autoimmune disease
New research suggests GLP-1s may reduce the risks of blood clots and early death in people with both obesity and autoimmune ...
Cartesian Therapeutics, Inc. RNAC stock is up on Tuesday as the company is announcing a strategic licensing agreement with ...
GLP-1 RA use is linked to reduced risk for thromboembolic events, ED use, and more among adults with obesity and autoimmune diseases.
Shares of Cartesian Therapeutics rose in premarket trading Tuesday after the company struck a deal to use WestGene Biopharma's lipid-nanoparticle delivery technology for its therapies for autoimmune ...
Bialik’s situation is one that other GLP-1 users have echoed. According to the Mayo Clinic, the most commonly reported side ...
WestGene’s established targeted LNP platform combined with Cartesian’s mRNA payload from Descartes-08 integrates two independently, clinically ...
New research from the Snow Centre for Immune Health is challenging long-held assumptions about autoimmune disease, revealing ...
Knowable Magazine reports on a revolutionary CAR T-cell therapy, originally for cancer, now showing promise for autoimmune ...
James Dallamangus, one of Australia's most wanted fugitives, has been arrested in Greece after nearly three decades on the run.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results